TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $108,397 | -83.3% | 6,900 | -82.5% | 0.06% | -84.4% |
| Q1 2023 | $650,310 | +5.6% | 39,461 | 0.0% | 0.40% | -8.9% |
| Q4 2022 | $615,598 | +20.2% | 39,461 | -0.0% | 0.44% | +2.6% |
| Q3 2022 | $512,000 | +8.9% | 39,464 | +18.0% | 0.43% | +15.1% |
| Q2 2022 | $470,000 | -1.7% | 33,450 | +0.2% | 0.37% | +18.2% |
| Q1 2022 | $478,000 | +25.1% | 33,378 | +19.1% | 0.31% | +29.3% |
| Q4 2021 | $382,000 | – | 28,025 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |